Business Wire

MI-EATON

13.9.2022 12:31:36 CEST | Business Wire | Press release

Share
Eaton’s Royal Power Solutions to display commercial vehicle terminals and connectors portfolio at IAA Transportation show

Power management company Eaton announced Royal Power Solutions (RPS), a leading provider of high-precision electrical connectivity components that it acquired earlier this year, is now providing its industry-leading components to commercial vehicle manufacturers. RPS components will be displayed Sept. 20-25 in Eaton’s exhibit at the IAA Transportation show in Hannover, Germany.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220913005003/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Eaton’s Royal Power Solutions is an industry-leading provider of critical high-precision power- and signal-distribution terminals and connectors. (Photo: Business Wire)

RPS, established in 1938, is a global leader in the development and production of critical high-precision power- and signal-distribution terminals and connectors. Eaton is utilizing RPS products in its eMobility business and expanding its global market opportunities, including in Europe, Middle East and Africa (EMEA).

“Eaton’s global footprint and diversification have broadened Royal Power Solutions’ reach and ability to grow in EMEA,” said Tom Ross, president, Eaton’s Royal Power Solutions. “The market for terminals and connectors in EMEA continues to expand in parallel with electrification solutions, which are being increasingly adopted by our commercial vehicle customers.”

Electrified commercial vehicles need more power than traditional passenger vehicles to operate varying systems. RPS, recognized for its numerous industry-leading electrical solutions, provides terminals, connectors and other electrical components designed to handle current levels up to 500 amps. Among those components are stamped battery and eyelet terminals that can withstand vibration and harsh environments, making them ideal for commercial vehicles.

High Power Lock Box connectors provide protection, superior performance

Eaton’s RPS specialized High Power Lock Box (HPLB) power connectors are ideal for current electrified commercial vehicle solutions and can help reduce common warranty issues. The HPLB connectors offer superior performance, cost savings and reduced manufacturing complexity. They also provide efficiency and reliability and are strong enough to withstand high-pressure water spray.

HPLB terminals are a “plug-in” solution with a smaller footprint, resulting in less weight and a reduced profile compared to traditional terminals. Eaton’s RPS uses a progressive stamping process to manufacture the HPLB profiles rather than the more costly complex billet machining, stamping and forming process that competitive products require.

Unlike traditional male-to-female terminal connections, Eaton’s RPS HPLB terminals use a unique inverted contact system that provides improved contact force as the temperature increases, creating a stronger connection.

RPS busbars feature low profile, flexibility to meet design requirements

Another RPS component now available to Eaton’s EMEA commercial vehicle customers is RigiFlexTM busbars, manufactured in copper or aluminum based on customer requirements. With a unique, simple, single-piece flow manufacturing process, Eaton can scale volume to meet any customer specification.

The RigiFlex busbar is rigid in some areas but flexible in sections that require elevation changes within the system design. This flexibility also works well across the battery pack in areas that need tolerance for expansion and contraction due to fluctuating temperatures during charging and discharging cycles.

Eaton’s RPS busbars have a low profile to enable space-efficient design without heat sinks, which leads to weight savings. Eaton also can produce busbars with a level of flatness over length unmatched by competitors, which fulfills size and design requirements. Eaton’s RPS can leverage an automated assembly process to provide superior safety, reduce production time and offer maximum cost savings with little wasted material and nearly zero development time for production products.

Eyelet terminals sealed, protected against galvanic corrosion

Eaton’s eyelet terminals, another RPS solution, are crafted with sophisticated engineering and produced in our state-of-the-art stamping facilities. Sourcing eyelet terminals from RPS provides numerous benefits, including the ability to produce billions of parts annually for the single sourcing of large programs.

Traditionally, eyelet terminals in commercial vehicle electrical components are not sealed, exposing them to road spray and salt that accelerate galvanic corrosion. Eaton’s eyelet terminals from RPS provide fully sealed connectors that are resistant to severe vibration and deliver a component service life exceeding customer requirements.

“RPS has decades of design, manufacturing and stamping experience that is being leveraged in the introduction of new energy-transfer technologies,” Ross said. “Many of the components RPS supplies, including eyelets, busbars, High Power Lock Box terminals and full-service connectors, are essential in today’s commercial vehicles.”

Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. Eaton is guided by its commitment to do business right, operate sustainably, and to help its customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, Eaton is accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for its stakeholders and all of society.

Founded in 1911, Eaton has been listed on the NYSE for nearly a century. We reported revenues of $19.6 billion in 2021 and serve customers in more than 170 countries. For more information, visit www.eaton.com. Follow us on Twitter and LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220913005003/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release

Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie

IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release

IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi

Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release

Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M

Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release

Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr

Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 07:00:00 CEST | Press release

The ruling confirms that Beerenberg did not infringe Aspen Aerogels’ patents. The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. Th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye